Featured Research

from universities, journals, and other organizations

Stimulant marketed as 'natural' in sports supplement actually of synthetic origin, study suggests

Date:
July 12, 2012
Source:
Wiley
Summary:
A new study found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually composed of synthetic compounds.

A new study published in the journal Drug Testing and Analysis found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually composed of synthetic compounds.

The substance DMAA (1,3-dimethylamylamine) is a stimulant existing in various pre-workout supplements and often labeled as part of geranium plants. The safety and origin of DMAA in these supplements is often the subject of intense debate and has been recently linked to the death of two U.S. soldiers, causing the Army to pull the supplement from its commissaries.

Researchers led by Daniel W. Armstrong, Ph.D., of the University of Texas at Arlington, set out to determine the unique isomeric ratios of synthetic substances (DMAA) and natural substances which are distinctly different and therefore can be used to distinguish between the two. Eight different geranium extracts of different geographical origins were examined for the presence of DMAA. No DMAA was found in any of the geranium extracts.

Results showed that the DMAA actually consists of 4 different compounds called stereoisomers and that the unique isomeric ratios in synthetic DMAA were the same as those found for the DMAA in all supplements. Thus, the DMAA in supplements could not have originated from the geranium plant.

"The FDA should regulate and/or ban products in which significant amounts of synthetic pharmacological compounds are added," Armstrong opined. "Also, this information should be clearly labeled -- including their effects and possible side effects -- so that consumers can make an informed choice.


Story Source:

The above story is based on materials provided by Wiley. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ying Zhang, Ross M. Woods, Zachary S. Breitbach, Daniel W. Armstrong. 1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? Drug Testing and Analysis, 2012; DOI: 10.1002/dta.1368

Cite This Page:

Wiley. "Stimulant marketed as 'natural' in sports supplement actually of synthetic origin, study suggests." ScienceDaily. ScienceDaily, 12 July 2012. <www.sciencedaily.com/releases/2012/07/120712131721.htm>.
Wiley. (2012, July 12). Stimulant marketed as 'natural' in sports supplement actually of synthetic origin, study suggests. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2012/07/120712131721.htm
Wiley. "Stimulant marketed as 'natural' in sports supplement actually of synthetic origin, study suggests." ScienceDaily. www.sciencedaily.com/releases/2012/07/120712131721.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins